Does PROTALIX BIOTHERAPEUTICS, INC. have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores PROTALIX BIOTHERAPEUTICS, INC. (PLX) 55.7 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 67, returns on capital 53, balance-sheet safety 55, capital discipline 44.

How has PLX's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 55.7 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

PROTALIX BIOTHERAPEUTICS, INC.

PLX · Healthcare · $191.4M mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power67

Median gross margin 58.1% over 10y, variable.

Returns on capital53

Median ROIC 11.8%, above the 9% hurdle in 67% of years.

Balance-sheet safety55

Net cash position — no leverage risk.

Capital discipline44

Owner earnings trend unclear, share count n/a.

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): —
Est. intrinsic value / share: —
Recent price: $2.38
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for PLX yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale55.7 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — PLX has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#95 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#93BRKR BRUKER CORPORATION55.9 out of 100, Shallow moatShallow moat
#94HIMS HIMS & HERS HEALTH, INC.55.8 out of 100, Shallow moatShallow moat
#96RIGL RIGEL PHARMACEUTICALS INC55.2 out of 100, Shallow moatShallow moat
#97KNSA Kiniksa Pharmaceuticals International, plc55.0 out of 100, Shallow moatShallow moat

Compare PLX with its nearest peers →All Healthcare companies on the Index →

Common questions about PLX

Does PROTALIX BIOTHERAPEUTICS, INC. have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores PROTALIX BIOTHERAPEUTICS, INC. (PLX) 55.7 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 67, returns on capital 53, balance-sheet safety 55, capital discipline 44.
How has PLX's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 55.7 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows PLX’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/PLX"
  width="340" height="150" style="border:0"
  title="PLX Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell PLX. See the disclaimer.